US$ 20.63
glp 1 agonism Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics Can one drug do it
Description
Injectable therapies remain the standard for both indications, but patient expectations differ

Following this, 11 studies met the inclusion criteria and data was extracted for the systematic review

By reducing this, GLP-1 drugs may protect organs and improve overall health

Diabetes Res Clin Pract 186:109806

Pratley RE, Reusch JE, Fleck PR, Wilson CA, Mekki Q

Specific concerns: Skin reactions
